Antibiotic administration in targeted nanoparticles protects the faecal microbiota of mice
- 15 January 2021
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 12 (3) , 380-383
Abstract
Antibiotic therapy comes with disturbances on human microbiota, resulting in changes of bacterial communities and thus leading to well-established health problems. In this study, we demonstrated that targeted teicoplanin administration maintains the faecal microbiota composition undisturbed in a mouse model while reaching therapeutic improvements for S. aureus infection.Keywords
This publication has 18 references indexed in Scilit:
- The challenge of antimicrobial resistance: What economics can contributeScience, 2019
- Intestinal Microbiota Influences Non-intestinal Related Autoimmune DiseasesFrontiers in Microbiology, 2018
- Antibiotic-Induced Changes in the Intestinal Microbiota and DiseaseTrends in Molecular Medicine, 2016
- Prevotella2015
- Aptamers: Molecular Tools for Medical DiagnosisCurrent Topics in Medicinal Chemistry, 2015
- Antibiotic loaded nanocapsules functionalized with aptamer gates for targeted destruction of pathogensChemical Communications, 2015
- Shifting the balance: antibiotic effects on host–microbiota mutualismNature Reviews Microbiology, 2011
- Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbationProceedings of the National Academy of Sciences of the United States of America, 2010
- Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD miceDiabetologia, 2009
- Aptamers: molecular tools for analytical applicationsAnalytical and Bioanalytical Chemistry, 2007